諾華公司 - 存託憑證（普通股）
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
分享價格
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionAbel Hall, LLC
Latest Disclosed Ownership14,499 shares
Latest Disclosed Value $ 2,214,772
Abel Hall, LLC reports 16.78% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 28, 2026 - Abel Hall, LLC filed a 13F-HR form disclosing ownership of 14,499 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $1,863,122 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 12,416 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 16.78% during the quarter. The current value of the position is $1,754,379 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 14,499 2,083 16.78 2,215 29.40 0.4718
2026-02-17 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 12,416 7,523 153.75 1,712 172.89 0.3998
2025-11-17 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,893 710 16.97 628 23.91 0.2534
2025-07-23 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,183 -531 -11.26 506 -3.62 0.2340
2025-05-06 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,714 922 24.31 526 42.28 0.3172
2025-01-23 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,792 82 2.21 369 -13.38 0.2352
2024-11-15 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,710 157 4.42 427 12.70 0.2794
2024-07-25 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,553 351 10.96 378 22.33 0.2676
2024-05-08 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,202 92 2.96 310 -1.59 0.2318
2024-02-28 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,110 3,110 314 0.2681
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.